Hip Manipulation for Improved Strength in Patients With Hip Pain

July 17, 2025 updated by: Andrews University

Effects of Unrestrained Femoral Internal Rotation Manipulation on Hip External Rotation Strength in Individuals With Nonspecific Hip Pain: A One-Week Follow-Up Clinical Trial

The purpose of this study is to investigate the potential effects of an unrestrained femoral internal rotation (UFIR) manipulation technique on hip external rotation strength in individuals with nonspecific hip pain. The results of this study may help physical therapists and other healthcare professionals to better understand the effectiveness of this technique in improving hip strength and function in patients with nonspecific hip pain.

Study Overview

Detailed Description

Background and Rationale

Hip pain is a prevalent and debilitating condition affecting adults of all ages and activity levels, with significant impact on daily function. In athletes, the rates of hip injuries are particularly high. The heterogeneity of nonspecific hip pain, coupled with limited research on accurate diagnosis and treatment, poses challenges for physical therapists.

This study focuses on the potential of joint manipulation, particularly the Unrestrained Femoral Internal Rotation (UFIR) technique, to improve hip external rotation strength in individuals with nonspecific hip pain and weakness. While strength training is commonly used to address hip weakness, there's a lack of research on alternative approaches like joint manipulation. This research seeks to bridge this gap and explore the potential benefits of UFIR manipulation in enhancing hip function and reducing pain.

Research Procedures

Design: Prospective, randomized, controlled trial Setting: SKYE Physiotherapy, Columbia, MD Sample: 24 adults (18-55 years) with nonspecific hip pain and ipsilateral hip external rotation weakness Intervention: Experimental group receives UFIR manipulation, control group receives sham manipulation Outcome Measures: Bilateral hip external rotation strength assessed by manual muscle testing (MMT) and hand-held dynamometer (HHD) at baseline, immediately post-intervention, and 1-week follow-up.

Data Analysis: Descriptive statistics, Friedman test, Kruskal-Wallis test, ANOVA, and repeated measures ANOVA will be used to analyze data.

Study Procedures

Recruitment: Participants will be recruited through flyers and social media platforms.

Screening and Enrollment: Eligible participants will complete an electronic health screening form and provide informed consent.

Randomization: Participants will be randomly assigned to either the experimental or control group.

Intervention: The examiner will administer UFIR manipulation to the experimental group and sham manipulation to the control group.

Assessments: Hip external rotation strength will be measured using MMT and HHD at baseline, immediately post-intervention, and at 1-week follow-up.

Data Analysis: Statistical analysis will be performed to assess changes in hip external rotation strength within and between groups.

Internal Validity and Generalizability

The study acknowledges potential threats to internal validity, including testing effects, instrumental bias, and experimenter bias. Measures to mitigate these threats include standardized techniques, a one-week interval between assessments, and randomization. The study aims to recruit a diverse sample from Howard County, MD, to enhance external validity and generalizability of findings.

Conclusion

This study aims to contribute to the understanding of the potential benefits of joint manipulation, specifically UFIR, in improving hip external rotation strength and function in individuals with nonspecific hip pain and weakness. The findings may inform clinical practice and provide alternative treatment options for this patient population.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Columbia, Maryland, United States, 21044
        • SKYE Physiotherapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • individuals who meet the following inclusion criteria will be eligible to participate in this study: 1) nonspecific hip pain, 2) ipsilateral hip external rotation weakness (at or below 3+) based on the MMT test

Exclusion Criteria:

  • individuals who meet any of the following exclusion criteria will not be eligible to participate in this study: 1) do not speak English, 2) have an impaired cognition and are unable to follow multi-step commands, 3) require an assistive device for standing balance, 4) have complaints of intractable (intolerable) pain, 5) have a history of hip dislocation or total hip replacement, 6) have a history of hip fracture or arthroscopy in the past 6 months, 7) have a history of lumbar spine fracture or surgery (e.g., lumbar discectomy and fusion) in the past 6 months, 8) present with neurological condition (i.e., stroke, Parkinson's disease, or lumbar radiculopathy), 9) known congenital hip dysplasia/adolescent hip disease, and 10) known osteoporosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Participants receiving the Unrestrained Femoral Internal Rotation (UFIR) manipulation.
This is the primary intervention applied to the experimental group. It involves a high-velocity, low-amplitude thrust at the greater trochanter of the affected hip, intended to improve joint mobility and potentially address neuromuscular dysfunction contributing to hip pain and weakness.
Placebo Comparator: Control Group
Participants receiving a sham manipulation (gentle hand placement)
This serves as the control intervention. It involves gentle hand placement over the affected hip's external rotators for a brief duration. This is intended to mimic the physical contact of the UFIR manipulation without actually delivering the therapeutic thrust.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in hip external rotation strength (measured in pounds using a hand-held dynamometer)
Time Frame: Baseline (pre-intervention), immediately post-intervention, and one-week follow-up
Baseline (pre-intervention), immediately post-intervention, and one-week follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 4, 2024

Primary Completion (Actual)

February 15, 2025

Study Completion (Actual)

February 15, 2025

Study Registration Dates

First Submitted

October 22, 2024

First Submitted That Met QC Criteria

October 22, 2024

First Posted (Actual)

October 24, 2024

Study Record Updates

Last Update Posted (Actual)

July 18, 2025

Last Update Submitted That Met QC Criteria

July 17, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Pain

Clinical Trials on Unrestrained Femoral Internal Rotation (UFIR) manipulation

Subscribe